Logan Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Logan Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,256	Closed	-$1.94M	–	303
2025 Q4	$1.79M	Sell	33,256 -1,259	-4%	-$60.6K	0.08%	172
2025 Q3	$1.56M	Hold	34,515	–	–	0.07%	186
2025 Q2	$1.6M	Sell	34,515 -1,329	-4%	-$65.2K	0.07%	175
2025 Q1	$2.19M	Sell	35,844 -4	-0%	-$233	0.1%	166
2024 Q4	$2.03M	Sell	35,848 -3,987	-10%	-$223K	0.09%	180
2024 Q3	$2.06M	Buy	39,835 +49	+0.1%	+$2.3K	0.08%	182
2024 Q2	$1.65M	Sell	39,786 -5,382	-12%	-$241K	0.07%	189
2024 Q1	$2.45M	Sell	45,168 -660	-1%	-$33.6K	0.1%	170
2023 Q4	$2.35M	Buy	45,828 +8	+0%	+$420	0.11%	167
2023 Q3	$2.66M	Buy	45,820 +133	+0.3%	+$8.15K	0.14%	152
2023 Q2	$2.92M	Sell	45,687 -441	-1%	-$29.6K	0.14%	145
2023 Q1	$3.2M	Sell	46,128 -4,847	-10%	-$342K	0.16%	140
2022 Q4	$3.67M	Buy	50,975 +13,173	+35%	+$993K	0.19%	127
2022 Q3	$2.69M	Buy	37,802 +547	+1%	+$39.7K	0.16%	130
2022 Q2	$2.87M	Sell	37,255 -609	-2%	-$46.4K	0.16%	135
2022 Q1	$2.77M	Sell	37,864 -49	-0.1%	-$3.29K	0.13%	141
2021 Q4	$2.36M	Sell	37,913 -655	-2%	-$38.4K	0.1%	160
2021 Q3	$2.28M	Buy	38,568 +3	+0%	+$198	0.11%	147
2021 Q2	$2.58M	Buy	38,565 +420	+1%	+$27.4K	0.12%	143
2021 Q1	$2.41M	Buy	38,145 +4	+0%	+$249	0.12%	143
2020 Q4	$2.37M	Sell	38,141 -336	-0.9%	-$20.7K	0.12%	144
2020 Q3	$2.32M	Buy	38,477 +500	+1%	+$30.1K	0.13%	172
2020 Q2	$2.23M	Sell	37,977 -470	-1%	-$28.1K	0.13%	131
2020 Q1	$2.14M	Sell	38,447 -499	-1%	-$30.5K	0.15%	141
2019 Q4	$2.5M	Buy	38,946 +29,872	+329%	+$1.71M	0.14%	141
2019 Q3	$460K	Hold	9,074	–	–	0.03%	254
2019 Q2	$412K	Sell	9,074 -52	-0.6%	-$2.42K	0.02%	263
2019 Q1	$435K	Sell	9,126 -68	-0.7%	-$3.39K	0.03%	258
2018 Q4	$478K	Hold	9,194	–	–	0.04%	232
2018 Q3	$571K	Hold	9,194	–	–	0.04%	230
2018 Q2	$509K	Hold	9,194	–	–	0.04%	230
2018 Q1	$582K	Hold	9,194	–	–	0.04%	222
2017 Q4	$563K	Buy	9,194 +52	+0.6%	+$3.25K	0.04%	217
2017 Q3	$583K	Hold	9,142	–	–	0.04%	211
2017 Q2	$509K	Hold	9,142	–	–	0.04%	215
2017 Q1	$497K	Buy	9,142 +274	+3%	+$15K	0.04%	214
2016 Q4	$519K	Buy	8,868 +68	+0.8%	+$3.72K	0.04%	222
2016 Q3	$475K	Sell	8,800 -112	-1%	-$7.19K	0.04%	223
2016 Q2	$655K	Sell	8,912 -14,888	-63%	-$1.05M	0.06%	197
2016 Q1	$1.52M	Hold	23,800	–	–	0.12%	125
2015 Q4	$1.64M	Hold	23,800	–	–	0.13%	120
2015 Q3	$1.41M	Sell	23,800 -1,500	-6%	-$95.2K	0.12%	125
2015 Q2	$1.68M	Hold	25,300	–	–	0.12%	124
2015 Q1	$1.63M	Sell	25,300 -3,700	-13%	-$232K	0.12%	121
2014 Q4	$1.71M	Sell	29,000 -2,500	-8%	-$141K	0.12%	120
2014 Q3	$1.61M	Hold	31,500	–	–	0.12%	114
2014 Q2	$1.53M	Hold	31,500	–	–	0.11%	116
2014 Q1	$1.64M	Hold	31,500	–	–	0.12%	113
2013 Q4	$1.67M	Sell	31,500 -2,500	-7%	-$127K	0.12%	118
2013 Q3	$1.57M	Sell	34,000 -6,062	-15%	-$266K	0.12%	116
2013 Q2	$1.44M	Buy	+40,062	New	+$1.74M	0.12%	126

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Logan Capital Management's BMY Position: Q1 2026 in Review

Logan Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 33,256 shares — an estimated $1.94M sold.

Logan Capital Management first reported a position in BMY in Q2 2013 and held it in 51 quarters. The position peaked at $3.67M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Logan Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 33,256 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.94M.
Logan Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 51 quarters.
Logan Capital Management's Bristol-Myers Squibb position peaked at $3.67M in Q4 2022.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.